Rainbow Seed Fund News

Appoints Industry Veteran Glyn Edwards MBE as Chair Oxford, England, 25 April 2022 – MitoRx Therapeutics (MitoRx), a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction to arrest the progression of degenerative diseases, announces the close of its seed financing. Financial details are not disclosed. The company also announces the appointment of Glyn Edwards […]

read more

Coventry, United Kingdom, 10th March 2022 / Sciad Newswire / NanoSyrinx, a biotech company using synthetic biology approaches to develop a new modality for the targeted intracellular delivery of biologic therapeutics, has strengthened its management team with the appointment of Dr Marie McAvoy as its Chief Scientific Officer. Dr McAvoy joins NanoSyrinx from GSK where she was Senior Director in […]

read more

London, UK, 19th July 2021 / The UK Innovation and Science Seed Fund (UKI2S) is pleased to announce the appointment of Dr Andrew Mackintosh as the new Chair of its Advisory Board. UKI2S enables and accelerates the commercial success of innovative companies from the UK’s publicly funded research base ranging from nuclear fusion to agrifoods and from synthetic […]

read more

1 2 3 5